🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Prospective, double-blind, randomized assessment of the efficacy, safety an...
Status
Completed
Location
Research Site 1
Start Date
2017-03-29
Trial ID
NCT03027609
This Study Aims to Evaluate the Safety, Tolerability and Efficacy of R2R01 ...
Status
Completed
Location
Thomas Hospital
Start Date
2024-03-01
Trial ID
NCT06264310
This clinical study will be a prospective, placebo-controlled, double-blind...
Status
Unknown
Location
Northwestern University Feinberg School of Medicine
Start Date
2015-11
Trial ID
NCT02602184
The objective is to compare the efficacy and safety of masitinib in combina...
Status
Not Yet Recruiting
Location
Aiginition Hospital
Start Date
2026-01-01
Trial ID
NCT07174492
Treatments Being Tested
The purpose of the study is to assess the safety and efficacy of targeted i...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01508910
Treatments Being Tested
The study is a randomized controlled, open-label trial comparing subcutaneo...
Status
Completed
Location
OLVZ Aalst
Start Date
2020-05-22
Trial ID
NCT04382755
Treatments Being Tested
The interventional, randomized, placebo-controlled, double-blind phase II-t...
Status
Recruiting
Location
University Hospital Heidelberg
Start Date
2025-07-16
Trial ID
NCT05690048
The proposed Phase IIB/III randomized, double-blind, placebo-controlled tri...
Status
Active Not Recruiting
Location
Institut Cancerologie de L'Ouest (ICO)
Start Date
2019-12-01
Trial ID
NCT04250922
The MONET BRIDGE study is designed to assess the use of cangrelor as a plat...
Status
Unknown
Location
Multiple Locations
Start Date
2019-06-01
Trial ID
NCT03862651
Treatments Being Tested
EMBRACE is a double-blind, randomized, placebo-controlled, phase IIa study ...
Status
Active Not Recruiting
Location
1st Department of Internal Medicine, Thriasio Elefsis General Hospital
Start Date
2025-03-22
Trial ID
NCT06694701
Treatments Being Tested